The Effect of Gastric Bypass on Cholesterol, HDL, and the Risk of Coronary Heart Disease.

A review of 150 charts revealed that 36 patients had pro-operative serum cholesterol greater than 200 mg% prior to Roux-Y gastric bypass. The average pre-operative weight was 266 lb (121 kg) and at 1 year postoperative 166 lb. (75 kg), or 100 lb.

Roux-Y Gastric Bypass: an effective anti-reflux procedure.

Gastric limiting procedures have made an improvement in the lives of those patients in whom they have been successful. Not only have there been marked improvements in diabetes, hypertension, and arthritis, but there have been a number a number of other 'spin-offs', not the least of which is control of reflux esophagitis by totally eliminating the secretion of the parietal cell mass of the stomach from rising into the esophagus. We compared a group of 100 obese patients with reflux esophagitis who underwent Roux-Y gastric bypass (RYGBP) to a normalisized group of 23 patients on whom we had done Nissen fundoplications in the past.